Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SciClone Pharmaceuticals Inc

+ Add to Watchlist

SCLN:US

8.8800 USD 0.0500 0.57%

As of 20:10:00 ET on 04/17/2015.

Snapshot for SciClone Pharmaceuticals Inc (SCLN)

Open: 8.7500 Day's Range: 8.6000 - 8.9200 Volume: 405,749
Previous Close: 8.8300 52wk Range: 4.5100 - 9.6500 1-Yr Rtn: +95.59%

Stock Chart for SCLN

No chart data available.
  • SCLN:US 8.8800
  • 1D
  • 1M
  • 1Y
8.8300
Interactive SCLN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SCLN

Current P/E Ratio (ttm) 14.4277
Estimated P/E(12/2015) 20.6512
Relative P/E vs. SPX 0.7855
Earnings Per Share (USD) (ttm) 0.6155
Est. EPS (USD) (12/2015) 0.4300
Est. PEG Ratio -
Market Cap (M USD) 444.50
Shares Outstanding (M) 50.06
30 Day Average Volume 461,242
Price/Book (mrq) 2.8565
Price/Sale (ttm) 3.3734
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SCLN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SCLN

SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The Company's products are for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.

Friedhelm BlobelPresident/CEOHong ZhaoCEO:China Operations
Wilson W CheungSenior VP:Finance/CFOCharles MengVP:Compliance/General Counsel
More Company Profile & Key Executives for SCLN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil